Berlin, Germany, July 24, 2023 – Epigenomics AG (Frankfurt Prime Standard: ECX1, OTCQX: EPGNY; the “Company”) entered today into an agreement (the “Agreement”) on the acquisition of almost all its assets with New Day Diagnostics LLC (the “Acquirer”). This successfully concludes the negotiations on such an agreement announced in the ad hoc dated June 12, 2023. Under the Agreement, the Company undertakes to transfer its patents as well as its entire biobank to the Acquirer and thus transfers all its assets within the meaning of Sec. 179a of the German Stock Corporation Act to the Acquirer. Therefore, in addition to other closing conditions, the agreement requires the approval of the shareholders'; meeting of the Company. The shareholders' meeting is scheduled for September 11, 2023, and, in addition to approving the Agreement, is also to resolve on the corresponding amendment to the corporate purpose of the Company. In return, the Company receives a purchase price of up to USD 12.05 million, which consists of the following elements:
In addition, the Company receives license payments and earn-out payments (mainly in the form of royalties on sales), which the Company will receive in the event of commercialization of Epi proColon “Next-Gen” until 2042 (when the patent ends).
Company Contact
Epigenomics AG, Geneststrasse 5, 10829 Berlin
Tel +49 (0) 30 24345 0, Fax +49 (0) 30 24345 555, Email: contact@epigenomics.com
Investor Relations
IR.on AG, Frederic Hilke, Tel +49 221 9140 970, Email: ir@epigenomics.com
Note on Forward-Looking Statements
This publication expressly or implicitly contains forward-looking statements concerning Epigenomics AG and its business. These statements involve certain known and unknown risks, uncertainties and other factors that may cause Epigenomics AG's actual results, financial condition and performance to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Epigenomics makes this announcement as of the date of this release and does not intend to update any forward-looking statements contained herein as a result of new information or future events or otherwise.
bullet list
numbered list
The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.
A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!
Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.
